​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 78.99% institutional investors, 11.49% insiders, and 9.52% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.29% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics78.99%11.49%9.52%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de15.68M15.17%$789.98M
Vanguard group10.12M9.79%$509.73M
Ingalls & snyder8.10M7.84%$408.15M
Renaissance6.20M6.00%$312.35M
Parallel advisors3.83M3.70%$192.98M
State street3.55M3.43%$178.80M
Dimensional fund advisors lp2.08M2.01%$104.74M
Geode capital management2.07M2.00%$104.24M
Arrowstreet capital, limited partnership1.64M1.59%$82.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder8.10M16.01%$408.15M
Tanaka capital management111.55K12.85%$5.62M
Parallel advisors3.83M4.34%$192.98M
Birchview capital, lp74.00K3.04%$3.73M
S&t bank/pa156.69K2.52%$7.90M
Synergy asset management462.41K1.73%$22.37M
Fas wealth partners309.21K1.31%$15.58M
Intrinsic edge capital management186.15K1.14%$9.38M
Lisanti capital growth77.67K0.94%$3.91M
Burney co/473.82K0.84%$23.88M

Top Buyers

HolderShares% AssetsChange
Norges bank834.59K0.01%834.59K
Qube research412.26K0.03%353.73K
Braun stacey associates296.39K0.56%296.39K
Millennium management508.36K0.01%269.13K
Synergy asset management462.41K1.73%262.50K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Ikarian capital---994.50K
Boston trust walden899.06K0.32%-614.91K
Kynam capital management, lp---585.90K
Bank of america corp /de/174.85K0.00%-498.50K

New Positions

HolderShares% AssetsChangeValue
Norges bank834.59K0.01%834.59K$42.06M
Braun stacey associates296.39K0.56%296.39K$14.94M
Raymond james financial239.80K0.00%239.80K$12.08M
Van eck associates88.97K0.01%88.97K$4.48M
Y-intercept (hong kong)42.02K0.14%42.02K$2.12M

Sold Out

HolderChange
Claris advisors, llc / mo /-6.00
Mendota financial group-7.00
Global financial private client-13.00
Nelson, van denburg & campbell wealth management group-16.00
High note wealth-28.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202544914.83%82,236,144-2.40%781.19%23615.12%14015.70%
Dec 31, 202438312.98%84,233,711-3.36%811.15%20015.61%12014.29%
Sep 30, 202433511.67%87,110,973-2.41%841.12%17420.00%101-11.40%
Jun 30, 2024295-4.53%89,230,600-3.86%861.06%141-16.07%11328.41%
Mar 31, 20243097.29%92,808,6509.52%901.35%16819.15%88-7.37%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.61M5.29%-15.84K
Vanguard Total Stock Mkt Idx Inv2.88M2.72%1.94K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Small Cap Index2.26M2.13%10.42K
iShares Russell 2000 ETF2.03M1.91%-
Vanguard Institutional Extnd Mkt Idx Tr1.45M1.37%11.86K
Vanguard Small Cap Growth Index Inv1.25M1.18%-6.33K
iShares S&P Small-Cap 600 Growth ETF831.13K0.78%-
Fidelity Small Cap Index817.00K0.77%9.49K
SPDR® Portfolio S&P 600™ Sm Cap ETF803.06K0.76%-

Recent Insider Transactions

DateNameRoleActivityValue
Jul 01, 2025Guyer William Chief Development OfficerSell$7.35K
Jul 01, 2025Lyon Joseph Douglas See RemarksSell$7.35K
Jul 01, 2025Maduck Sean See RemarksSell$15.06K
Jun 16, 2025Robb Gary Charles Chief Business OfficerSell$225.40K
Jun 10, 2025Swisher Daniel N JR-Sell$155.34K

Insider Transactions Trends

DateBuySell
2025 Q3-3
2025 Q2-36
2025 Q1-22
2024 Q4-7
2024 Q3-8

CORT Ownership FAQ

Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 78.99%, followed by 11.49% insiders and 9.52% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 63.84%, which Corcept Therapeutics exceeds.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (15.68M shares, 15.17%), and Vanguard group (10.12M shares, 9.79%). Together, they hold 41.04% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.01% of its assets in 8.1M Corcept Therapeutics shares, valued at 408.15M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.29% of its total shares outstanding invested in 5.61M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools